Japan
The generative AI healthcare agent aims to support clinicians by taking on time-consuming, non-diagnostic patient-facing tasks.
The study has demonstrated the potential of predictable movement stimuli as a behavioural marker of autism spectrum disorder.
Also, Heuron started expanding to Japan following an exclusive deal to supply its stroke imaging AI.
Also, Japan has approved one of JLK's stroke imaging AI solutions.
Kauvery Hospital invests in Lifesigns
Lifesigns has received undisclosed funding from Kauvery Hospital Group's investment arm, Healthcare Capital.